Carregant...

Antitumor effect of FP3 in a breast cancer xenograft model

FP3 is a novel vascular endothelial growth factor (VEGF) blocker proposed to have antiangiogenic properties. Previous studies revealed that FP3 is a new promising agent for treating human choroidal neovascularization (CNV)-associated age-associated macular degeneration (AMD) and has an inhibitory ef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: LAN, HUANRONG, ZHENG, LINGZHI, JIN, KETAO, TENG, LISONG
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3524272/
https://ncbi.nlm.nih.gov/pubmed/23251246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.773
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!